膝关节内注射后乳糖度的快速下降:对乳糖前期治疗的作用机制的影响
Kenneth Dean Reeves1, Jordan R Atkins2, Clare R Solso3
1Independent Researcher, Roeland Park, KS 66205, USA.
Biomedicines
|February 26, 2025
概括
关节内乳糖前期治疗 (DPT) 涉及高度的乳糖,但清除速度很快. 这项研究发现,注射后膝盖中的右糖水平迅速下降,这表明短时间的暴露时间会影响DPT的作用机制.
科学领域:
- 生物医学工程 生物医学工程
- 整形外科 整形外科 整形外科
- 药理学 药理学是指药理学的学科.
背景情况:
- 德克斯特前期疗法 (DPT) 使用高度的德克斯特注射来治疗疼痛,临床试验的支持越来越大.
- 对于DPT的确切作用机制尚不清楚,这阻碍了进一步的研究.
- 一种普遍存在的理论表明,高透性右诱导炎症,启动愈合级联,但体外模型缺乏关于体外右清除率的数据.
研究的目的:
- 为了确定内关节注射后人类膝盖中乳糖度下降的速度.
- 了解DPT后组织暴露于高度的右糖的持续时间.
主要方法:
- 一项N-of-1研究涉及一名70岁的男性,他三次向膝盖注射了12,500毫克的百分比乳糖.
- 从注射后7到360分钟进行了连续的突液吸血,以测量乳糖度.
- 使用 Minitab 和 GraphPad Prism 软件分析了乳糖清除动力学.
主要成果:
- 在所有试验中,乳糖度都迅速下降,遵循一个的,近指数曲线.
- 观察到第三阶化学反应模式,表明除了简单的稀释或输送活性之外的因素.
- 通过突膜的快速扩散被认为是快速脱素清除的贡献者.
结论:
- 在关节内注射30毫升12,500毫克%的乳糖,导致膝盖中的度迅速下降.
- 关节内细胞和组织在有限的时间内暴露在高度的右糖中.
- 这些发现对理解DPT的作用机制和改进体外研究设计有影响.
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
137
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
137
Local Anesthetics: Clinical Application as Spinal Anesthesia
570
Spinal anesthetics are given during lower abdomen and limb surgeries to block sensory and motor neurons. They are administered in the mid to low lumbar regions, primarily acting on the cauda equina's nerve roots. The blockade level depends on the local anesthetic (LA) concentration. Usually, low LA concentrations are sufficient to block sensory fibers, while only high LA concentrations block motor fibers. Other factors like injection volume and speed, the patient's posture, and the drug...
570
Hypoglycemia and Glucagon
149
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
149
Local Anesthetics: Pharmacokinetics
720
The potency and duration of action of local anesthetics (LAs) are determined by their pharmacokinetics. Pharmacokinetics describes how LAs are absorbed, distributed, metabolized, and eliminated from the body. When administered to the vascular tissues, LAs are quickly absorbed and enter the systemic circulation, reducing their localized effects. Adding vasoconstrictors such as epinephrine to LAs reduces their absorption into the systemic circulation, making them clinically effective. The...
720
Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K


